Giri Shibashish, Bader Augustinus
Department of Cell Techniques and Applied Stem Cell Biology, Center for Biotechnology and Biomedicine (BBZ), Medical Faculty, University of Leipzig, Leipzig, Germany.
J Clin Exp Hepatol. 2014 Sep;4(3):191-201. doi: 10.1016/j.jceh.2014.08.001. Epub 2014 Sep 18.
Generation of genetically stable and non-tumoric immortalization cell line from primary cells would be enormously useful for research and therapeutic purposes, but progress towards this goal has so far been limited. It is now universal acceptance that immortalization of human fetal hepatocytes based on recent advances of telomerase biology and oncogene, lead to unlimited population doubling could be the possible source for bioartificial liver device.
Immortalization of human fetal hepatocytes cell line by ectopic expression of human telomerase reverse transcriptase (hTERT), human papilloma virus gene (E7) and simian virus 40 large T (SV40 T) antigens is main goal of present study. We used an inducible system containing human telomerase and E7, both of which are cloned into responder constructs controlled by doxycycline transactivator. We characterized the immortalized human fetal hepatocyte cells by analysis of green fluorescent cells (GFP) positive cells using flow cytometry (FACs) cell sorting and morphology, proliferative rate and antigen expression by immunohistochemical analysis. In addition to we analysized lactate formation, glucose consumption, albumin secretion and urea production of immortalized human fetal hepatocyte cells.
After 25 attempts for transfection of adult primary hepatocytes by human telomerase and E7 to immortalize them, none of the transfection systems resulted in the production of a stable, proliferating cell line. Although the transfection efficiency was more than 70% on the first day, the vast majority of the transfected hepatocytes lost their signal within the first 5-7 days. The remaining transfected hepatocytes persisted for 2-4 weeks and divided one or two times without forming a clone. After 10 attempts of transfection human fetal hepatocytes using the same transfection system, we obtained one stable human fetal hepatocytes cell line which was able albumin secretion urea production and glucose consumption.
We established a conditional human fetal hepatocytes cell line with mesenchymal characteristics. Thus immortalization of human fetal hepatocytes cell line by telomerase biology offers a great challenge to examine basic biological mechanisms which are directly related to human and best cell source having unlimited population doubling for bioartificial support without any risk of replicative senescence and pathogenic risks.
从原代细胞生成基因稳定且无肿瘤形成的永生化细胞系对于研究和治疗目的将非常有用,但迄今为止朝着这一目标取得的进展有限。基于端粒酶生物学和癌基因的最新进展,人类胎儿肝细胞的永生化导致无限的群体倍增,这可能是生物人工肝装置的潜在来源,这一点现已得到普遍认可。
通过异位表达人端粒酶逆转录酶(hTERT)、人乳头瘤病毒基因(E7)和猿猴病毒40大T抗原(SV40 T)使人类胎儿肝细胞系永生化是本研究的主要目标。我们使用了一个包含人端粒酶和E7的诱导系统,二者均被克隆到由强力霉素反式激活因子控制的应答构建体中。我们通过使用流式细胞术(FACs)细胞分选分析绿色荧光细胞(GFP)阳性细胞以及形态学、增殖率和免疫组织化学分析抗原表达来对永生化的人类胎儿肝细胞进行表征。此外,我们分析了永生化的人类胎儿肝细胞的乳酸生成、葡萄糖消耗、白蛋白分泌和尿素产生情况。
在用人类端粒酶和E7转染成人原代肝细胞以使其永生化进行了25次尝试后,没有一个转染系统产生稳定的、增殖的细胞系。尽管第一天的转染效率超过70%,但绝大多数转染的肝细胞在最初的5 - 7天内失去了信号。其余转染的肝细胞持续2 - 4周,分裂一两次但未形成克隆。使用相同的转染系统对人类胎儿肝细胞进行10次转染尝试后,我们获得了一个稳定的人类胎儿肝细胞系,其能够进行白蛋白分泌、尿素产生和葡萄糖消耗。
我们建立了一个具有间充质特征的条件性人类胎儿肝细胞系。因此,通过端粒酶生物学使人类胎儿肝细胞系永生化对于研究直接与人类相关的基本生物学机制是一个巨大的挑战,并且是生物人工支持中具有无限群体倍增且无复制性衰老风险和致病风险的最佳细胞来源。